Novacyt S.A. (CDI)
NCYT · AIM · Health Care · mcap £29m today
All announcements
-
01 Oct 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9802858 ↗ -
30 Sep 262026 Interim Results
Paris, France, and Manchester, UK – 30 September 2026 – Novacyt S.A.
RNS 9797669 ↗ -
08 Sep 26Launch of IVDR-Certified Yourgene® DPYD Assay
Paris, France, and Manchester, UK - 8 September 2026 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a growing portfolio of integrated technologies and services, announces the commercial launch of the In...
RNS 9759938 ↗ -
01 Sep 26Master Collaboration Agreement with Illumina
Agreement supports evaluation of future collaboration and product development opportunities
RNS 9747179 ↗ -
03 Aug 26Liquidity Agreement Update and Total Voting Rights
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9701529 ↗ -
28 Jul 26Half-year trading update
Paris, France, and Manchester, UK - 28 July 2026 - Novacyt S.A.
RNS 9689846 ↗ -
01 Jul 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9648118 ↗ -
10 Jun 26
-
01 Jun 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9595487 ↗ -
01 Jun 26Operational Update
The information contained within this announcement is deemed by Novacyt S.A. to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.
RNS 9594582 ↗ -
19 May 26Launch of Yourgene® Insight DPYD assay
Paris, France and Manchester, UK - 19 May 2026 - Novacyt S.A.
RNS 9574282 ↗ -
07 May 26
-
05 May 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9553075 ↗ -
30 Apr 26Full Year 2025 results
Paris, France, and Manchester, UK - 30 April 2026 - Novacyt S.A.
RNS 9545298 ↗ -
01 Apr 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9503589 ↗ -
30 Mar 26Director/PDMR Shareholding Director buys
Paris, France, and Manchester, UK - 30 March 2026 - Novacyt S.A.
RNS 9498711 ↗ -
20 Mar 26Result of Preferential Subscription Rights Issue
Paris, France, and Manchester, UK - 20 March 2026 - Novacyt S.A.
RNS 9483508 ↗ -
02 Mar 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9454290 ↗ -
02 Mar 26Preferential Subscription Rights Issue
The information contained within this announcement is deemed by Novacyt S.A. to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.
RNS 9452457 ↗ -
02 Mar 26Completion of Acquisition
Paris, France, and Manchester, UK - 2 March 2026 - Novacyt S.A.
RNS 9452147 ↗ -
23 Feb 26Acquisition of Southern Cross Diagnostics
Paris, France, and Manchester, UK - 23 February 2026 - Novacyt S.A.
RNS 9441217 ↗ -
02 Feb 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9402421 ↗ -
27 Jan 26NIPT Tender Award
Contract signed with St George's University Hospitals NHS Foundation Trust
RNS 9387980 ↗ -
21 Jan 26Full year trading update
Paris, France and Manchester, UK - 21 January 2026 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), the international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces an unaudited full year trading...
RNS 9370751 ↗ -
02 Jan 26Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9330592 ↗ -
01 Dec 25Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9267715 ↗ -
03 Nov 25Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights
RNS 9209525 ↗ -
22 Oct 25Strategy update & notice of investor presentation
Paris, France, and Manchester, UK - 22 October 2025 - Novacyt S.A.
RNS 9185720 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.